About 200 Mg Sorafenib Tablets IP
Spotlighted within the medical community as a popular choice for oncology treatment, 200 Mg Sorafenib Tablets IP embody lofty standards of quality and efficacy. Manufactured in India, these peerless tablets feature the unprecedented benefits intrinsic to pure Sorafenib salt composition. Suited for widespread distribution, export, and trade, they offer unmatched shelf life of up to 24 months when stored in a dry place. The dosage form-tablet-ensures convenience for patients seeking proven oncology solutions. Grab yours from leading distributors, exporters, suppliers, and traders across India.
Clinical Use and Application
200 Mg Sorafenib Tablets IP are primarily used as an oral chemotherapeutic agent in the management of specific cancer types, including liver, kidney, and thyroid malignancies. Recommended for adult patients, the tablets are taken by mouth under careful medical supervision. The site of application is systemic, targeting cancer cells throughout the body. This product delivers reliable support within prescribed treatment regimens.
Sample Policy and Transportation Details
200 Mg Sorafenib Tablets IP samples are subject to clear drop-off policies at the designated FOB port in India. Sample availability hinges on current distributor and exporter rates, ensuring equitable terms for interested parties. Transportation is managed efficiently, aligning with industry standards for pharmaceutical shipments. The process supports timely product sampling, allowing traders and buyers to assess quality firsthand before purchasing.
FAQ's of 200 Mg Sorafenib Tablets IP:
Q: How should 200 Mg Sorafenib Tablets IP be stored to maintain efficacy?
A: The tablets must be kept in a dry place to preserve their pharmacological integrity and maximize the shelf life, which extends up to 24 months.
Q: What is the intended usage of 200 Mg Sorafenib Tablets IP?
A: These tablets are used orally as an anti-cancer medication, primarily indicated for liver, kidney, and thyroid cancers under the supervision of healthcare professionals.
Q: Where are the 200 Mg Sorafenib Tablets IP manufactured and exported from?
A: The product originates from India, with distribution, export, and supply facilitated by certified medical distributors, exporters, suppliers, and traders.
Q: What is the sample policy for 200 Mg Sorafenib Tablets IP?
A: Samples can be arranged based on current rates and policies, with drop-off at the designated FOB port in India for eligible parties intending to evaluate the product.
Q: When should patients seek guidance before using Sorafenib tablets?
A: Medical consultation is essential before beginning Sorafenib therapy to ensure appropriate usage, dosage, and management of potential side effects.
Q: How does the dosage form benefit patient convenience?
A: The tablet format allows for easy oral administration, improving patient adherence and convenience within prescribed cancer treatment plans.